ScinoPharm to attend the Web Investor Conference
held by SinoPac Securities
Date of events
2022/06/14
To which item it meets
paragraph 12
Statement
1.Date of institutional investor conference:2022/06/14
2.Time of institutional investor conference:14:00 (Taiwan Time)
3.Location of institutional investor conference:Online Conference
4.Outline of institutional investor conference:
Invited by SinoPac Securities, the Company will present its financial and
operating results that are already disclosed to the public.
5.Any other matters that need to be specified:
Please refer to MOPS or the Company's website for the presentation
materials.
Attachments
Original Link
Original Document
Permalink
Disclaimer
ScinoPharm Taiwan Ltd. published this content on 10 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 June 2022 09:51:04 UTC.
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of active pharmaceutical ingredients. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The Company is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.
SCINOPHARM TAIWAN, LTD. 
